Market Research Report
Global Non-Invasive Prenatal Testing (NIPT) Market - Analysis and Forecast 2017-2023: Focus on Test Type, Country Analysis (Test Volume & Value), APAC Countries by Test Type, Patent Landscape and Competitive Landscape
|Published by||BIS Research Inc.||Product code||498155|
|Published||Content info||224 Pages
Delivery time: 1-2 business days
|Global Non-Invasive Prenatal Testing (NIPT) Market - Analysis and Forecast 2017-2023: Focus on Test Type, Country Analysis (Test Volume & Value), APAC Countries by Test Type, Patent Landscape and Competitive Landscape|
|Published: April 30, 2017||Content info: 224 Pages||
This publication has been discontinued on October 25, 2018.
North America was the largest market for NIPT in 2016 in terms of revenue and volume. The region is expected to retain its leadership position throughout the forecast period as major players in the NIPT market are based in the U.S. (the largest shareholder in North America).
Non-invasive prenatal testing (NIPT) is an innovative way of screening pregnancies for fetal chromosomal aneuploidies by analyzing fetal cell-free DNA circulating in maternal blood. Amniocentesis, chorionic villus sampling (CVS), maternal serum screening, and nuchal translucency (NT) scan have been the primary diagnostic and screening methods for chromosomal abnormalities. The growth of NIPT market is attributed primarily to a rapid increase in genetic disorders/abnormalities, increase in fetal mortality, adoption of NIPT test in developed countries, and advancement of healthcare technologies.
In spite of enormous competition levels that prevails in the industry, the market growth is expected to be propelled by multiple factors such as rising demand for prenatal testing, adoption toward IVF procedures, increasing awareness among parents, and upsurge in the government spending on healthcare.
The research study has segmented the entire NIPT market into test value and volume, and geographical region including detail country analysis which enables the user gain a multi-dimensional view of the market. The research report employs an exhaustive and analytical approach to estimate and understand the market thus provides an all-inclusive insight into various forms of developments, market trends and strategies. While underlining the key driving and restraining factors for the NIPT market, the report also provides a comprehensive understanding in terms of competitive landscape, market share analysis, competitor benchmarking (matrices), and their positioning within the global NIPT market.
The report includes the company profiles for leading players in the NIPT market which enables the readers understand the current competitive scenario that prevails in this industry. Some of the key player include Roche, Natera, Illumina, LabCorp, LifeCodexx, BGI Diagnostics, Premaitha and Berry Genomics, among others.